196 related articles for article (PubMed ID: 17266109)
1. Towards understanding the schizophrenia code: an expanded convergent functional genomics approach.
Le-Niculescu H; Balaraman Y; Patel S; Tan J; Sidhu K; Jerome RE; Edenberg HJ; Kuczenski R; Geyer MA; Nurnberger JI; Faraone SV; Tsuang MT; Niculescu AB
Am J Med Genet B Neuropsychiatr Genet; 2007 Mar; 144B(2):129-58. PubMed ID: 17266109
[TBL] [Abstract][Full Text] [Related]
2. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.
Ogden CA; Rich ME; Schork NJ; Paulus MP; Geyer MA; Lohr JB; Kuczenski R; Niculescu AB
Mol Psychiatry; 2004 Nov; 9(11):1007-29. PubMed ID: 15314610
[TBL] [Abstract][Full Text] [Related]
3. Identifying blood biomarkers for mood disorders using convergent functional genomics.
Le-Niculescu H; Kurian SM; Yehyawi N; Dike C; Patel SD; Edenberg HJ; Tsuang MT; Salomon DR; Nurnberger JI; Niculescu AB
Mol Psychiatry; 2009 Feb; 14(2):156-74. PubMed ID: 18301394
[TBL] [Abstract][Full Text] [Related]
4. Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.
Le-Niculescu H; Balaraman Y; Patel SD; Ayalew M; Gupta J; Kuczenski R; Shekhar A; Schork N; Geyer MA; Niculescu AB
Transl Psychiatry; 2011 May; 1(5):e9. PubMed ID: 22832404
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of action of valproate acid alone or in combination with chlorpromazine in the epigenetic regulation of schizophrenia.
Geng YM; Xue JT; Su JP; Li HY
J Biol Regul Homeost Agents; 2018; 32(6):1443-1450. PubMed ID: 30574748
[TBL] [Abstract][Full Text] [Related]
6. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.
Ayalew M; Le-Niculescu H; Levey DF; Jain N; Changala B; Patel SD; Winiger E; Breier A; Shekhar A; Amdur R; Koller D; Nurnberger JI; Corvin A; Geyer M; Tsuang MT; Salomon D; Schork NJ; Fanous AH; O'Donovan MC; Niculescu AB
Mol Psychiatry; 2012 Sep; 17(9):887-905. PubMed ID: 22584867
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice.
Engel M; Snikeris P; Jenner A; Karl T; Huang XF; Frank E
Int J Neuropsychopharmacol; 2015 May; 18(7):pyu114. PubMed ID: 26478928
[TBL] [Abstract][Full Text] [Related]
8. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.
Cherlyn SY; Woon PS; Liu JJ; Ong WY; Tsai GC; Sim K
Neurosci Biobehav Rev; 2010 May; 34(6):958-77. PubMed ID: 20060416
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
[TBL] [Abstract][Full Text] [Related]
10. Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach.
Rodd ZA; Bertsch BA; Strother WN; Le-Niculescu H; Balaraman Y; Hayden E; Jerome RE; Lumeng L; Nurnberger JI; Edenberg HJ; McBride WJ; Niculescu AB
Pharmacogenomics J; 2007 Aug; 7(4):222-56. PubMed ID: 17033615
[TBL] [Abstract][Full Text] [Related]
11. Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.
Ruzicka WB; Subburaju S; Benes FM
JAMA Psychiatry; 2015 Jun; 72(6):541-51. PubMed ID: 25738424
[TBL] [Abstract][Full Text] [Related]
12. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
Abekawa T; Ito K; Koyama T
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):177-93. PubMed ID: 17103144
[TBL] [Abstract][Full Text] [Related]
13. ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers.
Tadmor H; Golani I; Doron R; Kremer I; Shamir A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():322-331. PubMed ID: 28818421
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenia: from genetics to biology to predictive medicine.
Niculescu AB
J Clin Psychiatry; 2014; 75 Suppl 2():4-7. PubMed ID: 24919164
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.
Hakak Y; Walker JR; Li C; Wong WH; Davis KL; Buxbaum JD; Haroutunian V; Fienberg AA
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4746-51. PubMed ID: 11296301
[TBL] [Abstract][Full Text] [Related]
16. Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice.
Beraki S; Diaz-Heijtz R; Tai F; Ogren SO
Int J Neuropsychopharmacol; 2009 Mar; 12(2):243-55. PubMed ID: 18684341
[TBL] [Abstract][Full Text] [Related]
17. Convergent functional genomics: a Bayesian candidate gene identification approach for complex disorders.
Bertsch B; Ogden CA; Sidhu K; Le-Niculescu H; Kuczenski R; Niculescu AB
Methods; 2005 Nov; 37(3):274-9. PubMed ID: 16308156
[TBL] [Abstract][Full Text] [Related]
18. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.
Santini MA; Ratner C; Aznar S; Klein AB; Knudsen GM; Mikkelsen JD
J Neurosci Res; 2013 May; 91(5):634-41. PubMed ID: 23404493
[TBL] [Abstract][Full Text] [Related]
19. Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice.
O'Tuathaigh CM; Harte M; O'Leary C; O'Sullivan GJ; Blau C; Lai D; Harvey RP; Tighe O; Fagan AJ; Kerskens C; Reynolds GP; Waddington JL
Eur J Neurosci; 2010 Jan; 31(2):349-58. PubMed ID: 20074216
[TBL] [Abstract][Full Text] [Related]
20. Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats.
Andrews JL; Newell KA; Matosin N; Huang XF; Fernandez-Enright F
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():91-7. PubMed ID: 26071990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
